Parkinson's disease is traditionally associated with neurological damage in the brain, brought on by a drastic drop in dopamine production, but a new study suggests it could get started in an unexpected part of the body: the kidneys.
Led by a team from Wuhan University in China, the study is primarily concerned with the alpha-synuclein (α-Syn) protein, which is closely associated with Parkinson's. When production goes awry and creates clumps of misfolded proteins, it interferes with brain function.
The key discovery here is that α-Syn clumps can build up in the kidneys, as well as the brain. The researchers think these abnormal proteins might actually travel from the kidneys to the brain, possibly playing a part in triggering the disease.
"We demonstrate that the kidney is a peripheral organ that serves as an origin of pathological α-Syn," write the researchers in their published paper.
There's a lot to dig into here. The research team ran multiple tests, looking at the behavior of α-Syn in genetically engineered mice, as well as analyzing human tissue – including samples from people with Parkinson's disease and chronic kidney disease.
The team found abnormal α-Syn growth in the kidneys of 10 out of 11 people with Parkinson's and other types of dementia related to Lewy bodies (a commonly seen type of α-Syn protein clumping).
The researchers took a close look at α-Syn protein levels in the kidneys of people with and without Parkinson's. (Yuan et al., Nature Neuroscience, 2025)That wasn't all: in another sample batch, similar protein malfunctions were found in 17 out of 20 patients with chronic kidney disease, even though these people had no signs of neurological disorders. This is more evidence that the kidneys are where these harmful proteins begin to gather, before brain damage begins.
The animal tests backed up these hypotheses. Mice with healthy kidneys cleared out injected α-Syn clumps, but in mice with kidneys that weren't functioning, the proteins built up and eventually spread to the brain. In further tests where the nerves between the brain and kidneys were cut, this spread didn't happen.
As α-Syn proteins can also move through the blood, the researchers tested this too. They found that a reduction in α-Syn in the blood also meant less damage to the brain, which means this is another consideration to bear in mind.
There are some limitations to this study. The number of people that tissue samples were taken from was relatively small, and while mice make decent stand-ins for humans in scientific research, there's no guarantee that the exact same processes observed in the animals are happening in people.
However, there are lots of interesting findings here that can be explored further, which could eventually aid in the development of new treatments for Parkinson's and other related neurological disorders.
The likelihood is that Parkinson's (in a similar way to Alzheimer's disease) is actually triggered in a variety of ways and through a variety of risk factors. For example, previous studies have also suggested it could get started in the gut – and now it seems the kidneys could be connected in a similar way.
"Removal of α-Syn from the blood may hinder the progression of Parkinson's disease, providing new strategies for therapeutic management of Lewy body diseases," write the researchers.
The research has been published in Nature Neuroscience.
Related News
These Common Drugs Can Make Coping With Heat Even Harder
Tinnitus Seems Somehow Linked to a Crucial Bodily Function
Your Ear Wax Might Hold Clues to Early Parkinson's, Study Finds
The study finding that Parkinson's Disease Might Not Start in the Brain challenges established knowledge, suggesting a different potential origin of symptoms may Link to peripheral tissues besides cerebral cortices.
The study suggesting that Parkinson's Disease might not originate in the brain but possibly manifest through regional changes outside it challenges conventional understanding, further emphasizing our incomplete knowledge of this complex disorder.
This study providing evidence that Parkinson's Disease might not start in the brain completely reverses our understanding of its origins, suggesting new avenues for early detection and intervention.
The study suggesting that Parkinson's Disease might not initiate in the brain delivers a refreshing perspective, emphasizing bouts of neurons outside our usual anatomical knowledge struggles as potential sparking points for this complex neurological disorder.
A study reveals that Parkinson's Disease might originate outside the brain, challenging current understanding of its initial pathogenesis.
The discovery that Parkinson's Disease may not initiate in the brain but elsewhere raises intriguing questions about its true origins, challenging conventional wisdom and demanding further investigation.
A recent study suggests that Parkinson's Disease may not originate in the brain, challenging our current understanding of its pathogenesis. This new find raises intriguing questions about how we should rethink and treat this debilitating condition.
A new study suggests that Parkinson's Disease may not originate in the brain as previously thought, challenging current understanding of its onset and highlighting a crucial area for future research.
Interestingly, the research suggests that Parkinson's Disease may initiate outside of traditional brain centers and this avenue might hold new avenues for diagnosis or treatment in future.
interestingly suggests that Parkinson's Disease may have a nonspecific initial appearance outside the brain, leaving neurologists and researchers with new avenues to explore.
This study raises important questions about the origin of Parkinson's Disease, suggesting that it might not always begin in traditional brain areas. Its findings could transform current understanding and treatment strategies for this widely misunderstood disorder."
This fascinating study suggests that Parkinson's Disease may not originate solely from brain abnormalities, challenging current understanding! Heart issues should be considered as potential start points for earlier diagnosis and treatment strategies.rego
When scientists find that Parkinson's Disease may not originate from the brain as previously believed, it paves new pathways through our understanding of neurodegeneration and must be thoroughly investigated for its implications towards diagnosis and treatment.
This study challenged the traditional view that Parkinson's Disease solely originates in brain dysfunction, suggesting potential neural pathways elsewhere. It opens up new avenues of research and treatment options.
A groundbreaking study suggests that Parkinson's Disease might not originate in the brain, challenging traditional assumptions about its cause and paving way for new lines of research.
